Pharmacovigilance (Drug Safety)
Ensuring continuous drug safety monitoring, adverse event management, and responsible healthcare practices through a robust pharmacovigilance system.
The Pharmacovigilance (Drug Safety) department at Bronson is dedicated to the continuous monitoring, assessment, and prevention of adverse effects associated with our products. Our primary objective is to ensure patient safety and maintain a favorable benefit–risk profile for all marketed formulations.
The team systematically collects and evaluates safety data from healthcare professionals, consumers, clinical studies, and post-marketing surveillance activities. Any reported adverse events are carefully analyzed, documented, and investigated to identify potential safety signals and implement appropriate corrective actions when necessary.
We maintain strict compliance with national and international pharmacovigilance guidelines and reporting requirements. Through timely communication with regulatory authorities and internal departments, we ensure rapid response to safety concerns and continuous improvement of product safety standards.
Bronson is committed to safeguarding public health by building a robust pharmacovigilance system that supports transparency, accountability, and the responsible use of all healthcare and herbal products.
Patient Safety
Continuous monitoring and evaluation to maintain product safety and patient well-being.
Adverse Event Monitoring
Collection, analysis, and documentation of adverse events to identify potential safety signals.
Regulatory Reporting
Compliance with national and international pharmacovigilance reporting standards and guidelines.
Risk Management
Proactive safety assessment and implementation of corrective actions to minimize healthcare risks.
